# A Trial of AN0025 With Chemoradiation Therapy in Stage III NSCLC Participants

> **NCT05358691** · PHASE1 · WITHDRAWN · sponsor: **Rutgers, The State University of New Jersey**

## Conditions studied

- Lung Cancer Stage III

## Interventions

- **DRUG:** AN0025

## Key facts

- **NCT ID:** NCT05358691
- **Lead sponsor:** Rutgers, The State University of New Jersey
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2024-11-01
- **Primary completion:** 2027-12-01
- **Final completion:** 2028-06-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** The research was cancelled
- **Last updated:** 2025-04-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05358691

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05358691, "A Trial of AN0025 With Chemoradiation Therapy in Stage III NSCLC Participants". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT05358691. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*